# MESALAMINE
> **ANDA213191** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS INC · Approved 2024-08-22
## Drug
- **FDA Application Number:** ANDA213191
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MESALAMINE
- **Generic name:** MESALAMINE
- **Active ingredients:** MESALAMINE
- **Dosage form:** TABLET, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS INC
- **Manufacturer:** Teva Pharmaceuticals, Inc.
- **First approval:** 2024-08-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213191)
---
*AI Analytics · CC0 1.0*